February 28, 2018 / 9:04 PM / 3 months ago

BRIEF-Aerie Pharmaceuticals Reports Q4 Adjusted Loss Per Share $1.38

Feb 28 (Reuters) - Aerie Pharmaceuticals Inc:

* AERIE PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE AND 2018 GUIDANCE

* Q4 GAAP LOSS PER SHARE $1.60

* ‍EXPECTS CASH BURN FOR FULL YEAR 2018 IN RANGE OF $200 MILLION TO $210 MILLION​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below